ECM
AGN

Everence Capital Management’s Allergan Inc AGN Stock Holding History

Everence Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-6,406
Closed -$1.49M – 305
2015
Q1 		$1.49M Buy
6,406
+894
+16% +$202K 0.5% 52
2014
Q4 		$1.17M Buy
5,512
+814
+17% +$162K 0.4% 70
2014
Q3 		$769K Hold
4,698
– – 0.28% 119
2014
Q2 		$795K Hold
4,698
– – 0.29% 114
2014
Q1 		$583K Hold
4,698
– – 0.23% 139
2013
Q4 		$522K Sell
4,698
-1,530
-25% -$146K 0.21% 148
2013
Q3 		$563K Hold
6,228
– – 0.24% 125
2013
Q2 		$525K Buy
+6,228
New +$646K 0.24% 126

Other funds holding AGN

MAM
Mark Asset Management New York $1.49B AUM 68.19% 1-Year Est. Return
NAMP
NorthStar Asset Management (Pennsylvania) Blue Bell, Pennsylvania $531M AUM 27.28% 1-Year Est. Return
CI
Chartist Inc Seal Beach, California $160M AUM 15.21% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
PAA
Peregrine Asset Advisers Portland, Oregon $461M AUM 43.48% 1-Year Est. Return
AWM
Altavista Wealth Management Asheville, North Carolina $496M AUM 20.88% 1-Year Est. Return
OFG
OTA Financial Group Purchase, New York $143M AUM 16.9% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
AAC
Asset Advisors Corp Augusta, Georgia $575M AUM 14.42% 1-Year Est. Return
ODCM
Old Dominion Capital Management Charlottesville, Virginia $467M AUM 25.94% 1-Year Est. Return

Everence Capital Management's AGN Position: Q2 2015 in Review

Everence Capital Management sold out of Allergan Inc (AGN) in Q2 2015, closing a stake of 6,406 shares — an estimated $1.49M sold.

Everence Capital Management first reported a position in AGN in Q2 2013 and held it in 8 quarters. The position peaked at $1.49M in Q1 2015. 35 funds tracked by Wall St. Rank hold AGN as of Q2 2015.

  • Everence Capital Management reported no remaining Allergan Inc position as of Q2 2015 after selling out during the quarter.
  • Everence Capital Management sold 6,406 Allergan Inc shares in Q2 2015, an estimated $1.49M.
  • Everence Capital Management first reported a position in Allergan Inc in Q2 2013 and held it in 8 quarters.
  • Everence Capital Management's Allergan Inc position peaked at $1.49M in Q1 2015.
  • 35 funds tracked by Wall St. Rank held Allergan Inc as of Q2 2015.

Based on Everence Capital Management's 13F filing for Q2 2015, filed 5 Aug 2015.